Potential mechanisms that could lead to the development of therapies which effectively manage progressive multiple sclerosis (MS), were identified by the researchers at the Advanced Science Research Center (ASRC) at the Graduate Center, CUNY and Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai. They published their findings in the journal iBrain/i.
The disability burden for people with multiple sclerosis (MS) can vary significantly depending on whether they have a ...
↧